Washington Drug Letter
Oct. 1, 2012
| Vol.
44 No.
39
PhRMA Petitions High Court to Reverse 3rd Circuit’s Anti-Pay-for-Delay Decision
PhRMA has asked the Supreme Court to take up and overturn the 3rd Circuit Court’s decision that reverses patent settlements between generics and branded drug makers violate antitrust law.
This article is viewable by subscribers only. To view this article, please select an option below.
|